Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M3XF
|
||||
Former ID |
DNC009872
|
||||
Drug Name |
1-(4-tert-butylphenylsulfonyl)-4-methoxyazepane
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H27NO3S
|
||||
Canonical SMILES |
CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)N2CCCC(CC2)OC
|
||||
InChI |
1S/C17H27NO3S/c1-17(2,3)14-7-9-16(10-8-14)22(19,20)18-12-5-6-15(21-4)11-13-18/h7-10,15H,5-6,11-13H2,1-4H3
|
||||
InChIKey |
XPMSNNNCHQEDRB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Corticosteroid 11-beta-dehydrogenase, isozyme 1 | Target Info | Inhibitor | [1] | |
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolism of xenobiotics by cytochrome P450 | |||||
Metabolic pathways | |||||
Chemical carcinogenesis | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
FSH Signaling Pathway | |||||
PathWhiz Pathway | Steroidogenesis | ||||
Reactome | Glucocorticoid biosynthesis | ||||
WikiPathways | Prostaglandin Synthesis and Regulation | ||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2009 Aug 15;19(16):4563-5. Epub 2009 Jul 8.The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.